<DOC>
	<DOCNO>NCT02675335</DOCNO>
	<brief_summary>The purpose study test effect Sitagliptin healing stable , nonhealing diabetic foot ulcer . This randomized placebo-controlled Trial .</brief_summary>
	<brief_title>Accelerated Wound Healing Diabetic Ulcers Sitagliptin</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>type 2 diabetes mellitus least 1 diabetic foot ulcer size 1 20 sqcm stable size foot ulcer least 2 week HbA1c &lt; = 8 % Treatment Insulin , metformin , sulfonylurea , SGLT2 Inhibitors , glinides glitazones local purulent sign Inflammation ulcer site plan interventional surgical therapy macro vessel disease lower limb glomerular filtration rate &lt; 30ml/min liver cirrhosis CHILD B C pregnancy , lactation allergy Sitagliptin ongoing treatment dipeptidyl peptidase 4 ( DPP4 ) Inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetic foot ulcer , Sitagliptin</keyword>
</DOC>